Overview
Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2024-06-01
2024-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The role of ultralong insulin in the control of the blood glucose level in diabetic patients is well known, the current study will discuss the role of ultralong insulin in controlling of hyperglycaemia in critical illness defined as failure or impending failure of an organPhase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Ain Shams UniversityTreatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc
Criteria
Inclusion Criteria:- Patients with Blood glucose level >250 mg/dl for more than 24 h
Exclusion Criteria:
- Age less than 18 or greater than 60 years Diabetic Ketoacidosis Patients with
recurrent episodes of hypoglycaemia Stress hyperglycemia Patients refusing to
participate in the study. Patients with renal insufficiency Patients on
corticosteroids